While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...

There’s about 270 different viruses that can infect humans, and in the fall and winter we're inside more where they can ...

Respiratory syncytial virus (RSV) remains the top cause of hospitalization among young children, leading to respiratory ...

COVID-19, influenza and RSV are the main threats between October and May. There are vaccines for all three viruses, so you may be wondering -- which do you need and can you get them at the same time?

COVID cases are already high in parts of the U.S., and RSV cases are also ticking up. The flu won't be far behind. With respiratory virus season rapidly approaching, the CDC is rolling out a new ...

But low uptake this season is, so far, in line with expectations. Fewer COVID-19 and RSV (respiratory syncytial virus) vaccines have been administered this year than were administered around the ...

Pfizer (NYSE:PFE) has reportedly succeeded in getting a U.K. court to invalidate two of GSK’s (NYSE:GSK) patents for its RSV vaccine. The ruling is part of ongoing litigation between the two ...

It's broadly defined to capture COVID-19, influenza, respiratory syncytial virus and other ... no longer required to report COVID admissions or capacity data, though the CDC encouraged reporting ...